BIRMINGHAM, Ala.--(BUSINESS WIRE)--Research findings presented at the American Heart Association (AHA) Scientific Sessions 2012 in Los Angeles will highlight the critical role the Atherotech patented VAP® Lipid Panel plays in improving cardiovascular risk stratification in heart disease research and clinical practice.
